Cost-effectiveness of β-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada

Abstract

OBJECTIVE: The purpose of this study was to estimate the cost-effectiveness of beta-blocker therapy with either metoprolol or carvedilol in addition to conventional therapy for patients with heart failure (HF) in Canada. DESIGN: A Markov simulation was used to estimate the costs and life expectancy for treating patients with conventional therapy alone and with the addition of metoprolol or carvedilol. Although carvedilol has been marketed in …

Authors

Levy AR; Briggs AH; Demers C; O’Brien BJ

Journal

American Heart Journal, Vol. 142, No. 3, pp. 537–543

Publisher

Elsevier

Publication Date

September 2001

DOI

10.1067/mhj.2001.116479

ISSN

0002-8703

Associated Experts

Catherine Demers

Professor, Faculty of Health Sciences

Visit profile

Labels